VivoSeq
Other

Patient Satisfaction

0

Pipeline Programs

2

Active Trials

6

Companies Involved

Patient Satisfaction is an early-stage landscape with 0 programs across 6 companies. The most active players are AbbVie, Biogen, Eli Lilly.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

12/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

34

clinical trials

Completed24 · 71%
Unknown status4 · 12%
Terminated2 · 6%
Withdrawn2 · 6%
Active, not recruiting1 · 3%
Not yet recruiting1 · 3%

Trial Activity

34 trials

Benepali® PEN Patient Satisfaction Survey
Completed·Biogen logoBiogen·N/A·NCT03327454·500 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)